CD4 and neoplasm: The importance of CD4+ T cells in the therapeutic efficacy of SA-4-1BBL/SVN vaccine was also demonstrated as 88% mice succumbed to tumor growth after depletion of CD4+ T cells one day before inoculation with 3LL tumor cells as compared with 20% mice in the non-depleted control group (Fig. 4C).